Tuesday, 29 June 2010

Clinical trial testing new Multiple Sclerosis treatment to launch in Buffalo

Researchers at the University at Buffalo, led by the Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy—dubbed “liberation treatment”—on MS symptoms and progression.

Read full article here